CLIC3
gene geneOn this page
Summary
CLIC3 (CLIC family member 3, HGNC:2064) is a protein-coding gene on chromosome 9q34.3, encoding Chloride intracellular channel protein 3 (O95833). In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor.
Chloride channels are a diverse group of proteins that regulate fundamental cellular processes including stabilization of cell membrane potential, transepithelial transport, maintenance of intracellular pH, and regulation of cell volume. Chloride intracellular channel 3 is a member of the p64 family and is predominantly localized in the nucleus and stimulates chloride ion channel activity. In addition, this protein may participate in cellular growth control, based on its association with ERK7, a member of the MAP kinase family.
Source: NCBI Gene 9022 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 43 total
- MANE Select transcript:
NM_004669
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2064 |
| Approved symbol | CLIC3 |
| Name | CLIC family member 3 |
| Location | 9q34.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000169583 |
| Ensembl biotype | protein_coding |
| OMIM | 606533 |
| Entrez | 9022 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000473911, ENST00000480181, ENST00000494426, ENST00000856092, ENST00000856093, ENST00000856094
RefSeq mRNA: 1 — MANE Select: NM_004669
NM_004669
CCDS: CCDS7021
Canonical transcript exons
ENST00000494426 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000870809 | 136995648 | 136995757 |
| ENSE00001897231 | 136996511 | 136996568 |
| ENSE00003513694 | 136994930 | 136995105 |
| ENSE00003640735 | 136994608 | 136994839 |
| ENSE00003672596 | 136995186 | 136995292 |
| ENSE00003684595 | 136995442 | 136995567 |
Expression profiles
Bgee: expression breadth ubiquitous, 193 present calls, max score 99.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 33.0542 / max 796.1795, expressed in 1006 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 103257 | 31.8207 | 972 |
| 103253 | 0.6820 | 263 |
| 103252 | 0.1685 | 112 |
| 103258 | 0.1407 | 75 |
| 103255 | 0.1159 | 12 |
| 103256 | 0.0477 | 6 |
| 103254 | 0.0470 | 20 |
| 103259 | 0.0317 | 9 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 99.64 | gold quality |
| oral cavity | UBERON:0000167 | 98.16 | gold quality |
| esophagus mucosa | UBERON:0002469 | 97.98 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 97.67 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 97.52 | gold quality |
| skin of abdomen | UBERON:0001416 | 97.30 | gold quality |
| skin of leg | UBERON:0001511 | 96.84 | gold quality |
| thyroid gland | UBERON:0002046 | 96.54 | gold quality |
| granulocyte | CL:0000094 | 96.32 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 95.92 | gold quality |
| zone of skin | UBERON:0000014 | 95.53 | gold quality |
| right lung | UBERON:0002167 | 95.50 | gold quality |
| gingiva | UBERON:0001828 | 95.32 | gold quality |
| placenta | UBERON:0001987 | 94.38 | gold quality |
| upper leg skin | UBERON:0004262 | 94.06 | gold quality |
| gingival epithelium | UBERON:0001949 | 94.05 | gold quality |
| corpus epididymis | UBERON:0004359 | 92.83 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 91.97 | gold quality |
| upper lobe of lung | UBERON:0008948 | 91.77 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 90.09 | gold quality |
| mammalian vulva | UBERON:0000997 | 89.60 | gold quality |
| penis | UBERON:0000989 | 89.48 | gold quality |
| upper arm skin | UBERON:0004263 | 89.20 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 88.93 | gold quality |
| vagina | UBERON:0000996 | 88.51 | gold quality |
| periodontal ligament | UBERON:0008266 | 87.91 | gold quality |
| amniotic fluid | UBERON:0000173 | 87.36 | gold quality |
| lower lobe of lung | UBERON:0008949 | 87.24 | silver quality |
| tongue squamous epithelium | UBERON:0006919 | 86.64 | gold quality |
| body of tongue | UBERON:0011876 | 86.28 | gold quality |
Single-cell (SCXA)
Detected in 16 experiment(s), a significant marker in 15.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8221 | yes | 5325.50 |
| E-GEOD-130473 | yes | 320.99 |
| E-HCAD-4 | yes | 144.88 |
| E-CURD-122 | yes | 56.17 |
| E-MTAB-6701 | yes | 45.93 |
| E-HCAD-10 | yes | 40.19 |
| E-MTAB-9467 | yes | 39.92 |
| E-CURD-46 | yes | 24.90 |
| E-CURD-88 | yes | 24.73 |
| E-MTAB-6678 | yes | 16.71 |
| E-HCAD-1 | yes | 15.43 |
| E-MTAB-8498 | yes | 13.49 |
| E-MTAB-9801 | yes | 6.39 |
| E-GEOD-130148 | yes | 5.26 |
| E-CURD-112 | no | 3.15 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): GATA3
Literature-anchored findings (GeneRIF, showing 10)
- CLIC3 facilitates chloride ion movement and regulates cellular processes associated with the movement of chloride in placental and fetal membrane cells. (PMID:17027078)
- The structure of the soluble form of CLIC3, is presented. (PMID:20146363)
- results suggest that increased expression of chloride intracellular channel 3 (CLIC3) may play a role in abnormal placental function associated with the human pregnancy disorders fetal growth restrict and pre-eclampsia (PMID:22795578)
- CLIC3 controls trafficking of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer. (PMID:25015290)
- in malignant pleural mesothelioma, the gene expressions of CLIC3 and CLIC4 were significantly increased compared to controls (PMID:26445368)
- CLIC3 is also secreted by cancer cells, is abundant in the stromal and tumour compartments of aggressive ovarian cancers and its levels correlate with poor clinical outcome. (PMID:28198360)
- Pathophysiological properties of CLIC3 chloride channel in human gastric cancer cells. (PMID:32066374)
- Identification of chloride intracellular channels as prognostic factors correlated with immune infiltration in hepatocellular carcinoma using bioinformatics analysis. (PMID:34766585)
- Chloride intercellular channel 3 suppression-mediated macrophage polarization: a potential indicator of poor prognosis of hepatitis B virus-related acute-on-chronic liver failure. (PMID:35238065)
- CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression. (PMID:38182571)
Cross-species orthologs
34 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | clic3 | ENSDARG00000044776 |
| mus_musculus | Clic3 | ENSMUSG00000015093 |
| rattus_norvegicus | Clic3 | ENSRNOG00000015184 |
| drosophila_melanogaster | GstD1 | FBGN0001149 |
| drosophila_melanogaster | GstD2 | FBGN0010038 |
| drosophila_melanogaster | GstD3 | FBGN0010039 |
| drosophila_melanogaster | GstD4 | FBGN0010040 |
| drosophila_melanogaster | GstD5 | FBGN0010041 |
| drosophila_melanogaster | GstD6 | FBGN0010042 |
| drosophila_melanogaster | GstD7 | FBGN0010043 |
| drosophila_melanogaster | GstD8 | FBGN0010044 |
| drosophila_melanogaster | GstE12 | FBGN0027590 |
| drosophila_melanogaster | Clic | FBGN0030529 |
| drosophila_melanogaster | GstT3 | FBGN0031117 |
| drosophila_melanogaster | GstE13 | FBGN0033381 |
| drosophila_melanogaster | GstE1 | FBGN0034335 |
| drosophila_melanogaster | GstE11 | FBGN0034354 |
| drosophila_melanogaster | GstD9 | FBGN0038020 |
| drosophila_melanogaster | GstD10 | FBGN0042206 |
| drosophila_melanogaster | GstT1 | FBGN0050000 |
| drosophila_melanogaster | GstT2 | FBGN0050005 |
| drosophila_melanogaster | GstE9 | FBGN0063491 |
| drosophila_melanogaster | GstE8 | FBGN0063492 |
| drosophila_melanogaster | GstE7 | FBGN0063493 |
| drosophila_melanogaster | GstE6 | FBGN0063494 |
| drosophila_melanogaster | GstE5 | FBGN0063495 |
| drosophila_melanogaster | GstE4 | FBGN0063496 |
| drosophila_melanogaster | GstE3 | FBGN0063497 |
| drosophila_melanogaster | GstE2 | FBGN0063498 |
| drosophila_melanogaster | GstE10 | FBGN0063499 |
| caenorhabditis_elegans | exc-4 | WBGENE00001365 |
| caenorhabditis_elegans | WBGENE00001371 | |
| caenorhabditis_elegans | gst-43 | WBGENE00001791 |
| caenorhabditis_elegans | WBGENE00021817 |
Paralogs (14): GSTO2 (ENSG00000065621), GSTT2 (ENSG00000099984), GSTZ1 (ENSG00000100577), GDAP1 (ENSG00000104381), CLIC5 (ENSG00000112782), GDAP1L1 (ENSG00000124194), GSTT2B (ENSG00000133433), GSTO1 (ENSG00000148834), CLIC2 (ENSG00000155962), CLIC6 (ENSG00000159212), CLIC4 (ENSG00000169504), CLIC1 (ENSG00000213719), EEF1G (ENSG00000254772), GSTT4 (ENSG00000276950)
Protein
Protein identifiers
Chloride intracellular channel protein 3 — O95833 (reviewed: O95833)
Alternative names: Glutaredoxin-like oxidoreductase CLIC3
All UniProt accessions (1): O95833
UniProt curated annotations — full annotation on UniProt →
Function. In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor. Reduced in a glutathione-dependent way and secreted into the extracellular matrix where it activates TGM2 and promotes blood vessel growth during tissue remodeling as occurs in tumorigenesis. Can reduce specific cysteines in TGM2 and regulate cofactor binding. Can insert into membranes and form outwardly rectifying chloride ion channels. May participate in cellular growth control.
Subunit / interactions. Associated with the C-terminal of MAPK15.
Subcellular location. Nucleus. Membrane. Cell membrane. Cytoplasm. Secreted. Extracellular space. Extracellular matrix.
Tissue specificity. Detected in placenta (at protein level). Widely expressed. High expression is found in placenta followed by lung and heart. Low expression in skeletal muscle, kidney and pancreas.
Activity regulation. Inhibited by rapamycin, amphotericin B and IAA-94.
Domain organisation. The active G-site contains a dithiol Cys-X-X-Cys motif which mediates glutathione-dependent redox catalysis. Members of this family may change from a globular, soluble state to a state where the N-terminal domain is inserted into the membrane and functions as a chloride channel. The redox status of the active cysteine in Cys-X-X-Cys motif likely determines the capacity to adopt a soluble or membrane-inserted state. A conformation change of the N-terminal domain is thought to expose hydrophobic surfaces that trigger membrane insertion.
Miscellaneous. Overexpression of CLIC3 is associated with cancer pathology; it positively correlates with pancreatic, ovarian and breast cancer prognosis and negatively with gastric cancer prognosis.
Similarity. Belongs to the chloride channel CLIC family.
RefSeq proteins (1): NP_004660* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002946 | CLIC | Family |
| IPR010987 | Glutathione-S-Trfase_C-like | Domain |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
| IPR036282 | Glutathione-S-Trfase_C_sf | Homologous_superfamily |
| IPR040079 | Glutathione_S-Trfase | Family |
| IPR053823 | CLIC_N | Domain |
Pfam: PF13410, PF22441
Catalyzed reactions (Rhea), 1 shown:
- chloride(in) = chloride(out) (RHEA:29823)
UniProt features (30 total): helix 11, strand 6, turn 2, domain 2, modified residue 2, chain 1, transmembrane region 1, mutagenesis site 1, region of interest 1, short sequence motif 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3FY7 | X-RAY DIFFRACTION | 1.95 |
| 3KJY | X-RAY DIFFRACTION | 1.95 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O95833-F1 | 94.08 | 0.86 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 49, 159
Disulfide bonds (1): 22–25
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 22 | decreases glutathione-dependent oxidoreductase activity toward tgm2. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 173 (showing top):
JAEGER_METASTASIS_DN, PEREZ_TP63_TARGETS, GOBP_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT, SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP, GOBP_INORGANIC_ANION_TRANSPORT, GOBP_SPROUTING_ANGIOGENESIS, KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP, GOBP_CHLORIDE_TRANSPORT, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_BLOOD_VESSEL_MORPHOGENESIS, GOBP_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS, FUJII_YBX1_TARGETS_UP, GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, LEE_AGING_CEREBELLUM_DN, GOBP_REGULATION_OF_SPROUTING_ANGIOGENESIS
GO Biological Process (6): chloride transport (GO:0006821), signal transduction (GO:0007165), positive regulation of sprouting angiogenesis (GO:1903672), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220), chloride transmembrane transport (GO:1902476)
GO Molecular Function (4): chloride channel activity (GO:0005254), protein-disulfide reductase (glutathione) activity (GO:0019153), protein binding (GO:0005515), oxidoreductase activity (GO:0016491)
GO Cellular Component (10): nucleus (GO:0005634), cytoplasm (GO:0005737), plasma membrane (GO:0005886), membrane (GO:0016020), nuclear body (GO:0016604), extracellular matrix (GO:0031012), chloride channel complex (GO:0034707), extracellular exosome (GO:0070062), extracellular region (GO:0005576), monoatomic ion channel complex (GO:0034702)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| monoatomic anion transport | 1 |
| inorganic anion transport | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sprouting angiogenesis | 1 |
| positive regulation of angiogenesis | 1 |
| regulation of sprouting angiogenesis | 1 |
| transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| chloride transport | 1 |
| monoatomic anion transmembrane transport | 1 |
| monoatomic anion channel activity | 1 |
| chloride transmembrane transporter activity | 1 |
| protein-disulfide reductase activity | 1 |
| oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor | 1 |
| binding | 1 |
| catalytic activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
| nucleoplasm | 1 |
| intracellular membraneless organelle | 1 |
| external encapsulating structure | 1 |
| monoatomic ion channel complex | 1 |
| extracellular vesicle | 1 |
| transmembrane transporter complex | 1 |
Protein interactions and networks
STRING
770 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CLIC3 | MAPK15 | Q8TD08 | 969 |
| CLIC3 | RAB25 | P57735 | 582 |
| CLIC3 | EZR | P15311 | 562 |
| CLIC3 | VSIG4 | Q9Y279 | 518 |
| CLIC3 | SNX17 | Q15036 | 460 |
| CLIC3 | PTDSS1 | P48651 | 449 |
| CLIC3 | CRABP2 | P29373 | 432 |
| CLIC3 | NEK9 | Q8TD19 | 430 |
| CLIC3 | LCNL1 | Q6ZST4 | 361 |
| CLIC3 | RFTN2 | Q52LD8 | 346 |
| CLIC3 | TMEM141 | Q96I45 | 339 |
| CLIC3 | GIPC1 | O14908 | 328 |
| CLIC3 | CLCA1 | A8K7I4 | 327 |
| CLIC3 | RAB11FIP1 | Q6WKZ4 | 326 |
| CLIC3 | RAB21 | Q9UL25 | 321 |
IntAct
116 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CLIC3 | EFHC2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| EFHC2 | CLIC3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CLIC3 | ZNF620 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | MBD3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | MECOM | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | ZC2HC1C | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | CIMIP2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | PROSER2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | GLYR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | INCA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | KATNBL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | ALX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | SPMIP6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | KRTAP13-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | MIA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | AGR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | SPMIP4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | DDIT4L | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | MSX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | VPS4A | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | KRT85 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB42 | CLIC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D3F | CLIC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | ANKRD55 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | TLE5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC3 | ANKRD23 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (64): EFHC2 (Two-hybrid), CLIC3 (Co-fractionation), CLIC3 (Co-fractionation), CLIC3 (Co-fractionation), SEPHS2 (Co-fractionation), CLIC3 (Affinity Capture-MS), CLIC3 (Proximity Label-MS), CLIC3 (Two-hybrid), CLIC3 (Two-hybrid), CLIC3 (Two-hybrid), CLIC3 (Two-hybrid), CLIC3 (Two-hybrid), CLIC3 (Two-hybrid), CLIC3 (Two-hybrid), CLIC3 (Two-hybrid)
ESM2 similar proteins: A0A0H3CDY2, O80662, O86043, O95833, P0A9D2, P0A9D3, P0AC59, P0AC60, P0AC61, P0ACA1, P0ACA2, P0ACA3, P0ACA4, P0ACA5, P0ACA6, P0ACA7, P0ACA8, P0ACA9, P15214, P30347, P31784, P44521, P45207, P45875, P49304, P50472, P76117, P77544, P81065, P82998, P94407, Q03520, Q12390, Q44571, Q476K0, Q51948, Q52828, Q52915, Q7VLK4, Q83AY0
Diamond homologs: O00299, O15247, O95833, P35526, Q29238, Q5E9B7, Q5M883, Q5R957, Q6MG61, Q811Q2, Q8BHB9, Q8BXK9, Q95MF9, Q96NY7, Q9D7P7, Q9EPT8, Q9N2G5, Q9NZA1, Q9QYB1, Q9XSA7, Q9Y696, Q9Z0W7, Q9Z1Q5, O45405, Q9VY78, P81124, A2XMN2, A6QQZ0, A8XT16, F4IA73, O09131, O43708, O88741, P0ACA3, P0ACA4, P0ACA5, P0ACA6, P28342, P30347, P31784
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
826 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:136994836:CCGT:C | acceptor_gain | 1.0000 |
| 9:136994837:CGTC:C | acceptor_gain | 1.0000 |
| 9:136994919:T:TA | donor_gain | 1.0000 |
| 9:136994928:A:AC | donor_gain | 1.0000 |
| 9:136994929:C:CC | donor_gain | 1.0000 |
| 9:136994929:CGT:C | donor_gain | 1.0000 |
| 9:136994931:TCG:T | donor_gain | 1.0000 |
| 9:136995101:CAGGG:C | acceptor_gain | 1.0000 |
| 9:136995106:C:CC | acceptor_gain | 1.0000 |
| 9:136995182:T:TA | donor_gain | 1.0000 |
| 9:136995184:ACCTT:A | donor_loss | 1.0000 |
| 9:136995185:C:A | donor_loss | 1.0000 |
| 9:136995188:T:A | donor_gain | 1.0000 |
| 9:136995191:T:TA | donor_gain | 1.0000 |
| 9:136995288:GGAAG:G | acceptor_gain | 1.0000 |
| 9:136995289:GAAG:G | acceptor_gain | 1.0000 |
| 9:136995290:AAG:A | acceptor_gain | 1.0000 |
| 9:136995291:AG:A | acceptor_gain | 1.0000 |
| 9:136995293:C:CC | acceptor_gain | 1.0000 |
| 9:136995297:G:T | acceptor_gain | 1.0000 |
| 9:136995300:A:AC | acceptor_gain | 1.0000 |
| 9:136995300:A:C | acceptor_gain | 1.0000 |
| 9:136995438:T:A | donor_gain | 1.0000 |
| 9:136995438:TCACT:T | donor_loss | 1.0000 |
| 9:136995439:CACT:C | donor_loss | 1.0000 |
| 9:136995440:A:AC | donor_gain | 1.0000 |
| 9:136995441:C:CT | donor_gain | 1.0000 |
| 9:136995441:CT:C | donor_gain | 1.0000 |
| 9:136995460:T:TA | donor_gain | 1.0000 |
| 9:136995463:T:TA | donor_gain | 1.0000 |
AlphaMissense
1534 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:136995674:G:C | F39L | 0.989 |
| 9:136995674:G:T | F39L | 0.989 |
| 9:136995676:A:G | F39L | 0.989 |
| 9:136994747:G:C | F215L | 0.988 |
| 9:136994747:G:T | F215L | 0.988 |
| 9:136994749:A:G | F215L | 0.988 |
| 9:136995235:G:C | F109L | 0.988 |
| 9:136995235:G:T | F109L | 0.988 |
| 9:136995237:A:G | F109L | 0.988 |
| 9:136994934:A:T | V183D | 0.987 |
| 9:136995686:C:A | K35N | 0.986 |
| 9:136995686:C:G | K35N | 0.986 |
| 9:136995226:G:C | F112L | 0.985 |
| 9:136995226:G:T | F112L | 0.985 |
| 9:136995228:A:G | F112L | 0.985 |
| 9:136994993:G:C | F163L | 0.984 |
| 9:136994993:G:T | F163L | 0.984 |
| 9:136994995:A:G | F163L | 0.984 |
| 9:136995523:G:T | P63H | 0.982 |
| 9:136996515:A:T | V10D | 0.980 |
| 9:136994779:A:C | Y205D | 0.978 |
| 9:136996517:A:C | F9L | 0.978 |
| 9:136996517:A:T | F9L | 0.978 |
| 9:136996519:A:G | F9L | 0.978 |
| 9:136994739:G:T | T218K | 0.977 |
| 9:136994960:G:C | C174W | 0.977 |
| 9:136994994:A:G | F163S | 0.976 |
| 9:136995227:A:G | F112S | 0.976 |
| 9:136995675:A:G | F39S | 0.976 |
| 9:136995716:G:C | C25W | 0.975 |
dbSNP variants (sampled 300 via entrez): RS1000031872 (9:136994144 G>A), RS1001006176 (9:136995137 C>A,T), RS1001786088 (9:136997998 G>A,T), RS1003868899 (9:136996716 G>C), RS1005406799 (9:136997909 A>G), RS1005470489 (9:136997370 C>G), RS1005768554 (9:136997691 C>T), RS1005814757 (9:136996036 A>C), RS1006641129 (9:136996996 C>T), RS1006691812 (9:136998481 G>A,T), RS1006935903 (9:136997279 C>G), RS1008780911 (9:136997416 C>T), RS1010143487 (9:136998490 C>T), RS1010853895 (9:136996593 A>G,T), RS1011828426 (9:136997439 T>C)
Disease associations
OMIM: gene MIM:606533 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
60 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Estradiol | decreases reaction, increases expression, decreases expression, affects cotreatment | 4 |
| Tobacco Smoke Pollution | affects expression, decreases expression | 3 |
| Cyclosporine | decreases expression | 3 |
| sodium arsenite | increases expression | 2 |
| (+)-JQ1 compound | decreases expression, increases expression | 2 |
| Air Pollutants | decreases expression, increases abundance | 2 |
| Smoke | increases abundance, decreases expression | 2 |
| Tetrachlorodibenzodioxin | increases expression | 2 |
| 8-Bromo Cyclic Adenosine Monophosphate | increases expression, affects cotreatment | 2 |
| GSK-J4 | decreases expression | 1 |
| afuresertib | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | decreases expression | 1 |
| deoxynivalenol | decreases expression | 1 |
| potassium perchlorate | decreases expression | 1 |
| pyrogallol 1,3-dimethyl ether | affects cotreatment, affects localization, decreases expression | 1 |
| decabromobiphenyl ether | decreases expression | 1 |
| afimoxifene | increases expression | 1 |
| sulforaphane | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| potassium chromate(VI) | increases expression | 1 |
| cupric chloride | decreases expression | 1 |
| hydroquinone | increases expression | 1 |
| 4-aminophenylarsenoxide | affects binding, decreases reaction | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| chromium hexavalent ion | decreases expression, increases abundance | 1 |
| entinostat | increases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.